Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP636616.RAKy_Uq-5j44gEhg1LxsrPDIkdhJlgficstxZRLwsGLno130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP636616.RAKy_Uq-5j44gEhg1LxsrPDIkdhJlgficstxZRLwsGLno130_assertion type Assertion NP636616.RAKy_Uq-5j44gEhg1LxsrPDIkdhJlgficstxZRLwsGLno130_head.
- NP636616.RAKy_Uq-5j44gEhg1LxsrPDIkdhJlgficstxZRLwsGLno130_assertion description "[Differentiation from neuroblastoma may be made based on immunoreactivity for beta 2 microglobulin and HBA71 and lack of immunoreactivity for chromogranin in PPNET and MSCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP636616.RAKy_Uq-5j44gEhg1LxsrPDIkdhJlgficstxZRLwsGLno130_provenance.
- NP636616.RAKy_Uq-5j44gEhg1LxsrPDIkdhJlgficstxZRLwsGLno130_assertion evidence source_evidence_literature NP636616.RAKy_Uq-5j44gEhg1LxsrPDIkdhJlgficstxZRLwsGLno130_provenance.
- NP636616.RAKy_Uq-5j44gEhg1LxsrPDIkdhJlgficstxZRLwsGLno130_assertion SIO_000772 7571088 NP636616.RAKy_Uq-5j44gEhg1LxsrPDIkdhJlgficstxZRLwsGLno130_provenance.
- NP636616.RAKy_Uq-5j44gEhg1LxsrPDIkdhJlgficstxZRLwsGLno130_assertion wasDerivedFrom befree-20140225 NP636616.RAKy_Uq-5j44gEhg1LxsrPDIkdhJlgficstxZRLwsGLno130_provenance.
- NP636616.RAKy_Uq-5j44gEhg1LxsrPDIkdhJlgficstxZRLwsGLno130_assertion wasGeneratedBy ECO_0000203 NP636616.RAKy_Uq-5j44gEhg1LxsrPDIkdhJlgficstxZRLwsGLno130_provenance.